Biotechnology
The companies featured on PressReleaseFinder are active in several industries.
3 May 2023
Actionable plans in place for reaching Perstorp 2030 sustainability targets
Sustainable solutions provider Perstorp has turned its ambitious sustainability targets for 2030 into actionable roadmaps on the corporate level as well as for each of its production plants, outlining hands-on activities to lower greenhouse gas emissions, reduce waste, save fresh water and enable sustainable transformation throughout the value chain.
7 Feb 2023
Perstorp sets reduction targets for water and waste
Sustainable solutions provider Perstorp has added new corporate sustainability targets, for water and waste, to its sustainability strategy. Its long-term sustainability ambition is to become Finite Material Neutral, which involves water and waste, along with raw materials, energy and catalysts. In 2021 the company set its first 2030 targets, for greenhouse gas emissions (using approved science-based targets) and (eco) toxic impact. Now Perstorp has added new sustainability targets that will address its long-term ambition.
Belgian textile innovator Devan Chemicals will launch Purissimo® NTL, a biobased and readily biodegradable allergen control technology, at the upcoming Heimtextil trade show in Frankfurt (January 10-13, 2023). It is based on the well-known probiotic encapsulation technology and aims to improve the lives of people who suffer from allergies. It can be applied to textiles during the finishing stage of the textile manufacturing process.
Sustainable solutions provider Perstorp is investing in a unique project that will allow it to use wastewater from a nearby municipal treatment plant for production operations in Stenungsund, Sweden. This will save 1.1 billion litres of fresh water per year.
With New York Market Week starting today, Devan Chemicals, part of the Pulcra Group, has unveiled its new bio-based CBD capsules. It’s also showcasing R-Vital® innovations and expanded cooling solutions for foam, including a bio-based version.
Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has today announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company. The acquisition forms a critical part of Malvern Panalytical’s strategy to expand its capabilities in support of drug discovery.